 | 2KT | Name: | 2-KETOBUTYRIC ACID | Formula: | C4 H6 O3 | SMILES: | O=C(C(=O)O)CC | InChi: | InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7) | Synonyms: | 2-OXOBUTANOIC ACID | Definition date: | 2003-12-10 | Last modified: | 2024-09-27 | Identifier: | 2-oxobutanoic acid |
|
 | LMR | Name: | (2S)-2-hydroxybutanedioic acid | Formula: | C4 H6 O5 | SMILES: | O=C(O)CC(O)C(=O)O | InChi: | InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/t2-/m0/s1 | Synonyms: | L-Malate | Definition date: | 2008-03-24 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-hydroxybutanedioic acid |
|
 | 2KY | Name: | (2S)-amino(cyclopentyl)ethanoic acid | Formula: | C7 H13 N O2 | SMILES: | O=C(O)C(N)C1CCCC1 | InChi: | InChI=1S/C7H13NO2/c8-6(7(9)10)5-3-1-2-4-5/h5-6H,1-4,8H2,(H,9,10)/t6-/m0/s1 | Definition date: | 2013-11-22 | Last modified: | 2024-09-27 | Release date: | 2018-02-28 | Identifier: | (2S)-amino(cyclopentyl)ethanoic acid |
|
 | 2L0 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-leucinamide | Formula: | C29 H49 N3 O6 | SMILES: | O=C(NC(CC(C)C)C(O)C(C)CO)C(NC(=O)C(NC(=O)OCc1ccccc1)CC(C)C)CC(C)C | InChi: | InChI=1S/C29H49N3O6/c1-18(2)13-23(26(34)21(7)16-33)30-27(35)24(14-19(3)4)31-28(36)25(15-20(5)6)32-29(37)38-17-22-11-9-8-10-12-22/h8-12,18-21,23-26,33-34H,13-17H2,1-7H3,(H,30,35)(H,31,36)(H,32,37)/t21-,23+,24+,25+,26+/m1/s1 | Synonyms: | PHQ-LEU-LEU-LEU-EPOXYKETONE, bound form | Definition date: | 2013-11-25 | Last modified: | 2024-09-27 | Release date: | 2014-02-12 | Identifier: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-leucinamide |
|
 | LN1 | Name: | (3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine | Formula: | C22 H22 N2 O9 S | SMILES: | O=C(OCC(S(=O)O)(C)C(C(=O)O)Nc2c(cc1ccccn12)C=O)Cc3ccc(O)c(O)c3 | InChi: | InChI=1S/C22H22N2O9S/c1-22(34(31)32,12-33-18(28)9-13-5-6-16(26)17(27)8-13)19(21(29)30)23-20-14(11-25)10-15-4-2-3-7-24(15)20/h2-8,10-11,19,23,26-27H,9,12H2,1H3,(H,29,30)(H,31,32)/t19-,22-/m0/s1 | Definition date: | 2008-05-15 | Last modified: | 2024-09-27 | Identifier: | (3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine |
|
 | 2L4 | Name: | 1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxoethylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol | Formula: | C11 H16 N4 O7 | SMILES: | O=C1NC(NCC(O)C(O)C(O)CO)=C(N=CC=O)C(=O)N1 | InChi: | InChI=1S/C11H16N4O7/c16-2-1-12-7-9(14-11(22)15-10(7)21)13-3-5(18)8(20)6(19)4-17/h1-2,5-6,8,17-20H,3-4H2,(H3,13,14,15,21,22)/b12-1+/t5-,6+,8-/m0/s1 | Synonyms: | 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil | Definition date: | 2013-11-25 | Last modified: | 2024-09-27 | Release date: | 2014-04-16 | Identifier: | 1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxoethylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol |
|
 | 2L5 | Name: | 2-chloro-L-phenylalanine | Formula: | C9 H10 Cl N O2 | SMILES: | Clc1ccccc1CC(C(=O)O)N | InChi: | InChI=1S/C9H10ClNO2/c10-7-4-2-1-3-6(7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1 | Definition date: | 2013-11-25 | Last modified: | 2024-09-27 | Release date: | 2014-10-15 | Identifier: | 2-chloro-L-phenylalanine |
|
 | 2L6 | Name: | (3S,6R,8aS)-5-oxo-1,2,3,8a-tetrahydrospiro[indolizine-6,2'-pyrrolidine]-3-carboxylic acid | Formula: | C12 H16 N2 O3 | SMILES: | O=C(O)C3N2C(=O)C1(NCCC1)C=CC2CC3 | InChi: | InChI=1S/C12H16N2O3/c15-10(16)9-3-2-8-4-6-12(5-1-7-13-12)11(17)14(8)9/h4,6,8-9,13H,1-3,5,7H2,(H,15,16)/t8-,9-,12+/m0/s1 | Definition date: | 2013-11-25 | Last modified: | 2024-09-27 | Release date: | 2014-10-15 | Identifier: | (3S,6R,8aS)-5-oxo-1,2,3,8a-tetrahydrospiro[indolizine-6,2'-pyrrolidine]-3-carboxylic acid |
|
 | LN5 | Name: | N5-(1-iminopropyl)-L-ornithine | Formula: | C8 H17 N3 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])CC | InChi: | InChI=1S/C8H17N3O2/c1-2-7(10)11-5-3-4-6(9)8(12)13/h6H,2-5,9H2,1H3,(H2,10,11)(H,12,13)/t6-/m0/s1 | Synonyms: | (2S)-2-azanyl-5-(propanimidoylamino)pentanoic acid | Definition date: | 2009-07-07 | Last modified: | 2024-09-27 | Identifier: | N~5~-[(1Z)-propanimidoyl]-L-ornithine |
|
 | LN7 | Name: | N~5~-[(1S)-1-aminopentyl]-L-ornithine | Formula: | C10 H23 N3 O2 | SMILES: | O=C(O)C(N)CCCNC(N)CCCC | InChi: | InChI=1S/C10H23N3O2/c1-2-3-6-9(12)13-7-4-5-8(11)10(14)15/h8-9,13H,2-7,11-12H2,1H3,(H,14,15)/t8-,9-/m0/s1 | Definition date: | 2010-10-20 | Last modified: | 2024-09-27 | Identifier: | N~5~-[(1S)-1-aminopentyl]-L-ornithine |
|
 | LNG | Name: | Delta-3isotetradecenoic acid | Formula: | C14 H26 O2 | SMILES: | O=C(O)CC=C/CCCCCCCC(C)C | InChi: | InChI=1S/C14H26O2/c1-13(2)11-9-7-5-3-4-6-8-10-12-14(15)16/h8,10,13H,3-7,9,11-12H2,1-2H3,(H,15,16)/b10-8- | Definition date: | 2004-07-16 | Last modified: | 2024-09-27 | Identifier: | (3Z)-12-methyltridec-3-enoic acid |
|
 | 2LJ | Name: | 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol | Formula: | C12 H20 N4 O6 | SMILES: | C1(=O)NC(NC(=C1N=CCC)NCC(O)C(O)C(O)CO)=O | InChi: | InChI=1S/C12H20N4O6/c1-2-3-13-8-10(15-12(22)16-11(8)21)14-4-6(18)9(20)7(19)5-17/h3,6-7,9,17-20H,2,4-5H2,1H3,(H3,14,15,16,21,22)/b13-3+/t6-,7+,9-/m0/s1 | Synonyms: | 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil | Definition date: | 2013-11-27 | Last modified: | 2024-09-27 | Release date: | 2014-04-16 | Identifier: | 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol |
|
 | LNK | Name: | PENTANE | Formula: | C5 H12 | SMILES: | CCCCC | InChi: | InChI=1S/C5H12/c1-3-5-4-2/h3-5H2,1-2H3 | Definition date: | 2001-05-15 | Last modified: | 2024-09-27 | Identifier: | pentane |
|
 | 2LR | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide | Formula: | C29 H47 N3 O6 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(C(O)C2(OC2)C)CC(C)C)CC(C)C)CC(C)C | InChi: | InChI=1S/C29H47N3O6/c1-18(2)13-22(25(33)29(7)17-38-29)30-26(34)23(14-19(3)4)31-27(35)24(15-20(5)6)32-28(36)37-16-21-11-9-8-10-12-21/h8-12,18-20,22-25,33H,13-17H2,1-7H3,(H,30,34)(H,31,35)(H,32,36)/t22-,23-,24-,25+,29+/m0/s1 | Synonyms: | PHQ-LEU-LEU-LEU-EPOXYKETONE, unbound form | Definition date: | 2013-11-28 | Last modified: | 2024-09-27 | Release date: | 2014-02-12 | Identifier: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide |
|
 | 2LT | Name: | 3,5-dichloro-L-tyrosine | Formula: | C9 H9 Cl2 N O3 | SMILES: | Clc1cc(cc(Cl)c1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H9Cl2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 | Definition date: | 2013-12-18 | Last modified: | 2024-09-27 | Release date: | 2014-09-24 | Identifier: | 3,5-dichloro-L-tyrosine |
|
 | LNR | Name: | L-NOREPINEPHRINE | Formula: | C8 H11 N O3 | SMILES: | Oc1ccc(cc1O)C(O)CN | InChi: | InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1 | Synonyms: | NORADRENALINE | Definition date: | 2001-03-28 | Last modified: | 2024-09-27 | Identifier: | 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol |
|
 | 2LV | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide | Formula: | C33 H48 N4 O6 | SMILES: | O=C(Nc1ccccc1)C(O)C(NC(=O)C(NC(=O)C(NC(=O)OCc2ccccc2)CC(C)C)CC(C)C)CC(C)C | InChi: | InChI=1S/C33H48N4O6/c1-21(2)17-26(29(38)32(41)34-25-15-11-8-12-16-25)35-30(39)27(18-22(3)4)36-31(40)28(19-23(5)6)37-33(42)43-20-24-13-9-7-10-14-24/h7-16,21-23,26-29,38H,17-20H2,1-6H3,(H,34,41)(H,35,39)(H,36,40)(H,37,42)/t26-,27-,28-,29-/m0/s1 | Synonyms: | PHQ-Leu-Leu-Leu-ketoamide, bound form | Definition date: | 2013-11-29 | Last modified: | 2024-09-27 | Release date: | 2014-02-12 | Identifier: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide |
|
 | LNT | Name: | N-[(2S)-2-amino-1,1-dihydroxy-4-methylpentyl]-L-threonine | Formula: | C10 H22 N2 O5 | SMILES: | O=C(O)C(NC(O)(O)C(N)CC(C)C)C(O)C | InChi: | InChI=1S/C10H22N2O5/c1-5(2)4-7(11)10(16,17)12-8(6(3)13)9(14)15/h5-8,12-13,16-17H,4,11H2,1-3H3,(H,14,15)/t6-,7+,8+/m1/s1 | Definition date: | 2007-11-07 | Last modified: | 2024-09-27 | Identifier: | N-[(2S)-2-amino-1,1-dihydroxy-4-methylpentyl]-L-threonine |
|
 | LOH | Name: | 3,4-dihydroxylysine | Formula: | C6 H14 N2 O4 | SMILES: | NCC[CH](O)[CH](O)[CH](N)C(O)=O | InChi: | InChI=1S/C6H14N2O4/c7-2-1-3(9)5(10)4(8)6(11)12/h3-5,9-10H,1-2,7-8H2,(H,11,12)/t3-,4-,5+/m0/s1 | Definition date: | 2017-09-08 | Last modified: | 2024-09-27 | Release date: | 2018-06-27 | Identifier: | (2~{S},3~{S},4~{S})-2,6-bis(azanyl)-3,4-bis(oxidanyl)hexanoic acid |
|
 | 51K | Name: | 2-(2-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}ethyl)-1,3,4-oxadiazole | Formula: | C14 H9 F6 N5 O | SMILES: | FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2nn(cn2)CCc3nnco3 | InChi: | InChI=1S/C14H9F6N5O/c15-13(16,17)9-3-8(4-10(5-9)14(18,19)20)12-21-6-25(24-12)2-1-11-23-22-7-26-11/h3-7H,1-2H2 | Synonyms: | KPT-251 | Definition date: | 2012-08-23 | Last modified: | 2024-09-27 | Release date: | 2012-08-31 | Identifier: | 2-(2-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}ethyl)-1,3,4-oxadiazole |
|
 | 51T | Name: | 2,3,6-trifluoro-L-tyrosine | Formula: | C9 H8 F3 N O3 | SMILES: | NC(Cc1c(cc(c(c1F)F)O)F)C(=O)O | InChi: | InChI=1S/C9H8F3NO3/c10-4-2-6(14)8(12)7(11)3(4)1-5(13)9(15)16/h2,5,14H,1,13H2,(H,15,16)/t5-/m0/s1 | Definition date: | 2015-07-13 | Last modified: | 2024-09-27 | Release date: | 2016-06-22 | Identifier: | 2,3,6-trifluoro-L-tyrosine |
|
 | LOR | Name: | LORACABEF (Open form) | Formula: | C16 H18 Cl N3 O4 | SMILES: | O=C(O)C2=NC(C(NC(=O)C(c1ccccc1)N)C=O)CCC2Cl | InChi: | InChI=1S/C16H18ClN3O4/c17-10-6-7-11(19-14(10)16(23)24)12(8-21)20-15(22)13(18)9-4-2-1-3-5-9/h1-5,8,10-13H,6-7,18H2,(H,20,22)(H,23,24)/t10-,11+,12+,13+/m0/s1 | Synonyms: | (3S,6R)-6-[(1S)-1-{[(2R)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-3-chloro-3,4,5,6-tetrahydropyridine-2-carboxylic
acid | Definition date: | 2000-08-11 | Last modified: | 2024-09-27 | Identifier: | (3S,6R)-6-[(1S)-1-{[(2R)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-3-chloro-3,4,5,6-tetrahydropyridine-2-carboxylic acid |
|
 | LOU | Name: | 3-[(3aR,4S,7S,7aS)-2-(carboxymethyl)-1,3-dioxooctahydro-4H-4,7-epoxyisoindol-4-yl]-L-alanine | Formula: | C13 H16 N2 O7 | SMILES: | C(CN1C(C2C(C1=O)C3OC2(CC(N)C(=O)O)CC3)=O)(=O)O | InChi: | InChI=1S/C13H16N2O7/c14-5(12(20)21)3-13-2-1-6(22-13)8-9(13)11(19)15(10(8)18)4-7(16)17/h5-6,8-9H,1-4,14H2,(H,16,17)(H,20,21)/t5-,6-,8+,9-,13-/m0/s1 | Definition date: | 2019-07-01 | Last modified: | 2024-09-27 | Release date: | 2019-10-16 | Identifier: | 3-[(3aR,4S,7S,7aS)-2-(carboxymethyl)-1,3-dioxooctahydro-4H-4,7-epoxyisoindol-4-yl]-L-alanine |
|
 | LOV | Name: | 5-AMINO-4-HYDROXY-2-ISOPROPYL-7-METHYL-OCTANOIC ACID | Formula: | C12 H25 N O3 | SMILES: | O=C(O)C(C(C)C)CC(O)C(N)CC(C)C | InChi: | InChI=1S/C12H25NO3/c1-7(2)5-10(13)11(14)6-9(8(3)4)12(15)16/h7-11,14H,5-6,13H2,1-4H3,(H,15,16)/t9-,10-,11-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S,4S,5S)-5-amino-4-hydroxy-7-methyl-2-(propan-2-yl)octanoic acid |
|
 | 523 | Name: | 2'-DEOXY-5-METHYLCYTIDINE 5'-(TETRAHYDROGEN TRIPHOSPHATE) | Formula: | C10 H19 N3 O13 P3 | SMILES: | O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC2OC([N+]=1C(=O)NC(N)=C(C=1)C)CC2O | InChi: | InChI=1S/C10H18N3O13P3/c1-5-3-13(10(15)12-9(5)11)8-2-6(14)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,14H,2,4H2,1H3,(H6,11,12,15,16,17,18,19,20,21,22)/p+1/t6-,7+,8+/m0/s1 | Synonyms: | 5-METHYL-2'-DEOXY-CYTIDINE-5'-TRIPHOSPHATE | Definition date: | 2007-01-22 | Last modified: | 2024-09-27 | Identifier: | 2'-deoxy-5-methylcytidine 5'-(tetrahydrogen triphosphate) |
|